CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Clearpoint Neuro Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Clearpoint Neuro Inc
120 S. SIERRA AVENUE, SUITE 100
Phone: (302) 658-7581p:302 658-7581 SOLANA BEACH, CA  92075  United States Ticker: MRICMRIC
Business Summary
ClearPoint Neuro, Inc. is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The Company provides clinical products and preclinical development services for controlled drug and device delivery. Its business consists of two components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. The primary applications for the ClearPoint system are to target and guide the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, and the infusion of pharmaceuticals into the brain. It provides consulting services to its pharmaceutical and other medical technology partners.
(Source: 6-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202612/31/2025YesYes---

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus
3845 Electromedical and electrotherapeutic apparatus
7372 Prepackaged software

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board R. JohnFletcher 80 2/4/2021 5/1/2017
President, Chief Executive Officer, Director Joseph M.Burnett 49 11/7/2017 11/7/2017
Chief Financial Officer DaniloD' Alessandro 41 1/1/2024 9/29/2020
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
CLEARPOINT NEURO ITALY S.R.L. CSO VERCELLI, 40 MILANO Italy
Irras AB Vasagatan 16 STOCKHOLM Sweden
CLEARPOINT NEURO UK LTD OLYMPUS AVENUE LEAMINGTON SPA WARWICKSHIRE United Kingdom

Business Names
Business Name
ClearPoint Holdings, LLC
ClearPoint Neuro (Canada) Inc.
ClearPoint Neuro Germany GmbH.
9 additional Business Names available in full report.

General Information
Number of Employees: 172 (As of 3/6/2026)
Outstanding Shares: 29,989,563 (As of 5/7/2026)
Shareholders: 184
Stock Exchange: NASD
Federal Tax Id: 582394628
Fax Number: (302) 655-5049


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, May 30, 2026